& Sulimani, R
Some reports suggest potential improvements in inflammatory markers or disease activity, while others note no significant effect or even symptom exacerbation related to gastrointestinal adverse effects
178 BoehmDKrzystek-KorpackaMNeubauerKMatusiewiczMParadowskiLGamianA
Food Industry: Shifting Consumer Demand and Healthcare System Implications GLP-1 therapies are poised to significantly reshape consumer food choices, with wide-ranging consequences for the food and beverage industry, public health, and the broader healthcare system
If prescribed, medication, syringes, alcohol pads, and instructions are provided as part of the program
characteristics which make it as a potential therapeutic agent in acute viral respiratory infections like influenza and influenzalike illnesses [16, 17]